New ADC phase 1 trial should start soon

[Maxone73]

LNCB74, a new antibody-drug conjugate, has received FDA approval to begin Phase 1 clinical trials. This drug targets the B7-H4 protein found on various cancer cells, including prostate cancer. B7-H4 suppresses the immune system, and LNCB74 aims to neutralize this protein and enable the immune system to destroy cancer cells. The Phase 1 trial will assess LNCB74's safety, optimal dosage, and preliminary effectiveness. Preclinical data suggests LNCB74 may have advantages over other similar drugs…🤞🤞

prostatewarriors.com/2024/1...

[Rolphs]

If there are enough shots on goal (and we live long enough) we can slay or at least shackle the PCa beast. 👹 Thanks again for keeping us updated!

[Maxone73 in reply to Rolphs]

We need a leo messi of research....or a Justin tucker 😀😀